Leaflet FEBUXOSTAT UNIVERSAL FARMA 120mg film-coated tablets

Product code:
W68771001
Quantity:
14
Indicated for:
gout; hyperuricemia
Route of administration:
oral
Substance:
febuxostat (xanthine oxidase inhibitor)
ATC
M04AA03 — Musculo-skeletal system | Antigout preparations | Antigout preparations | Preparations inhibiting uric acid production
Febuxostat is a selective xanthine oxidase inhibitor used for the treatment of chronic hyperuricemia in patients with gout. It works by reducing the production of uric acid, thereby preventing the formation of urate crystals.

The medication is taken orally, usually once daily, as directed by a doctor. It is important to monitor uric acid levels and renal function during treatment.

Side effects may include nausea, diarrhea, headache, or skin rashes. In rare cases, severe reactions such as liver failure or serious allergic reactions may occur.

Febuxostat is not recommended for patients with hypersensitivity to this medication or severe hepatic impairment.

General data about FEBUXOSTAT UNIVERSAL FARMA 120mg

Substance:
febuxostat
Date of latest medicines list:
01-06-2022
Product code:
W68771001
Concentration:
120mg
Pharmaceutical form:
film-coated tablets
Quantity:
14
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
LABORATORIOS LICONSA, S.A. - SPANIA
Holder:
LABORATORIOS LICONSA S.A. - SPANIA
Number:
11698/2019/01
Shelf life:
2 years

Concentrations available for febuxostat

  • 120mg
  • 80mg